secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001193125-24-019500
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics expands inducement equity plan by 500,000 shares for new hires
--------------------------------------------------------------------------------

- Board added 500,000 shares to 2020 Inducement Plan on January 24, 2024.
- Plan used to grant equity awards as material inducement for new employees and M&A hires.
- Amendment adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4).
- Total shares authorized under the Plan now 2,500,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524019500/0001193125-24-019500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524019500/d721921d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-019500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer